Latest total liabilities for AIMD: $16M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
The latest total liabilities for AIMD is $16M as of March 2026. That compares with $13M in the prior-year period — up 23.9% year over year. Investors often review this figure alongside Ainos's historical trend and sector peers before judging valuation or financial health.
Over the past year, AIMD's total liabilities moved from $13M to $16M — a 23.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Ainos's operating scale or balance-sheet position.
A total liabilities figure of $16M for AIMD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting AIMD's total liabilities ($16M), review year-over-year change from $13M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
This page's peer comparison chart is the fastest way to stack Ainos's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.